Literature DB >> 10715297

Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.

K J Henrickson1, R A Axtell, S M Hoover, S M Kuhn, J Pritchett, S C Kehl, J P Klein.   

Abstract

PURPOSE: To determine whether an antibiotic flush solution containing vancomycin, heparin, and ciprofloxacin (VHC) can prevent the majority of line infections. PATIENTS AND METHODS: A prospective double-blind study was performed comparing VHC to vancomycin and heparin (VH) to heparin alone in 126 pediatric oncology patients.
RESULTS: The 153 assessable lines resulted in 36,944 line days studied. There were 58 blood stream infections (43 gram-positive, 14 gram-negative, and one fungal). Forty were defined as line infections (31 heparin, three VH, six VHC). The time to develop a line infection was significantly increased using either antibiotic flush (VH, P =.011; VHC, P =.036). The rate of total line infections (VH, P =.004; VHC, P =.005), gram-positive line infections (VH, P =. 028; VHC, P =.022), and gram-negative line infections (VH, P =.006; VHC, P =.003) was significantly reduced by either VH or VHC. Sixty-two (41%) of the lines developed 119 occlusion episodes (heparin, 3.99 per 1,000 line days; VHC, 1.75 per 1,000 line days; P =.0005). Neither antibiotic could be detected after flushing, and no adverse events were detected, including increased incidence of vancomycin-resistant Enterococcus colonization or disease.
CONCLUSION: The use of either VH or VHC flush solution significantly decreased the complications associated with the use of tunneled central venous lines in immunocompromised children and would save significant health care resources.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715297     DOI: 10.1200/JCO.2000.18.6.1269

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  40 in total

1.  Nosocomial Infections in the Intensive Care Unit Associated with Invasive Medical Devices.

Authors:  Nasia Safdar; Christopher J. Crnich; Dennis G. Maki
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

Review 2.  Catheter-related infections in pediatric patients with cancer.

Authors:  V Cecinati; L Brescia; L Tagliaferri; P Giordano; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

3.  Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections.

Authors:  Mark L Kayton; Edward G Garmey; Nicole M Ishill; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Carol Rossetto; Courtney Hennelly; Melissa Parra Doyle; Shoshana Rosenberg; Olga Santoro; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2010-10       Impact factor: 2.545

Review 4.  Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition.

Authors:  D Hodge; J W L Puntis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

5.  Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro.

Authors:  P Kite; K Eastwood; S Sugden; S L Percival
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 6.  Metabolic and catheter complications of parenteral nutrition.

Authors:  Marwan S Ghabril; Jamie Aranda-Michel; James S Scolapio
Journal:  Curr Gastroenterol Rep       Date:  2004-08

Review 7.  Healthcare-associated infection prevention in pediatric intensive care units: a review.

Authors:  N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

Review 8.  Risk factors and prevention of late-onset sepsis in premature infants.

Authors:  L Corbin Downey; P Brian Smith; Daniel K Benjamin
Journal:  Early Hum Dev       Date:  2010-01-29       Impact factor: 2.079

Review 9.  Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections.

Authors:  Paschalis Vergidis; Robin Patel
Journal:  Infect Dis Clin North Am       Date:  2012-03       Impact factor: 5.982

Review 10.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.